HLA-E is significantly upregulated in ovarian cancer tissues, and HLA-E presents peptides to inhibitory receptor CD94/NKG2A or stimulatory receptor CD94/NKG2C expressing on the majority of NK cells. This evidence concerns the gene HLA-E and ovarian carcinoma.